FDA Advisory Panel Rejects Capricor Data While FTC Targets Hims & Hers

By Ed Silverman · STAT News · 2026-07-30

FDA Advisory Panel Rejects Capricor Data While FTC Targets Hims & Hers

According to STAT News, federal regulators delivered twin blows to the healthcare sector this week. An FDA advisory committee recently voted against the efficacy of a Duchenne muscular dystrophy treatment from Capricor Therapeutics, while the FTC initiated legal action against Hi

According to STAT News, federal regulators delivered twin blows to the healthcare sector this week. An FDA advisory committee recently voted against the efficacy of a Duchenne muscular dystrophy treatment from Capricor Therapeutics, while the FTC initiated legal action against Hi